MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.390
+0.020 (1.46%)
At close: Aug 21, 2026, 4:00 PM EDT
1.380
-0.010 (-0.72%)
After-hours: Aug 21, 2026, 7:55 PM EDT
MediciNova Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 25.42 | 30.81 | 40.36 | 51 | 18.51 | 71.43 |
Short-Term Investments | - | - | - | - | 39.98 | - |
Cash & Short-Term Investments | 25.42 | 30.81 | 40.36 | 51 | 58.49 | 71.43 |
Cash Growth | -25.81% | -23.67% | -20.86% | -12.80% | -18.12% | 18.98% |
Prepaid Expenses | 0.51 | 0.18 | 0.71 | 0.17 | 0.5 | 0.58 |
Total Current Assets | 25.92 | 30.99 | 41.07 | 51.17 | 58.99 | 72.01 |
Property, Plant & Equipment | 0.11 | 0.19 | 0.38 | 0.62 | 0.67 | 0.88 |
Goodwill | 9.6 | 9.6 | 9.6 | 9.6 | 9.6 | 9.6 |
Other Intangible Assets | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 |
Other Long-Term Assets | - | 0.02 | 0.02 | 0.07 | 0.09 | 0.12 |
Total Assets | 40.43 | 45.6 | 55.88 | 66.27 | 74.15 | 87.41 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.95 | 0.62 | 1.1 | 1 | 0.42 | 0.4 |
Accrued Expenses | 1.89 | 2.46 | 1.54 | 1.89 | 2.42 | 1.75 |
Current Portion of Leases | 0.12 | 0.19 | 0.19 | 0.22 | 0.16 | 0.13 |
Current Unearned Revenue | - | 0.37 | - | - | - | - |
Other Current Liabilities | - | 0.15 | 0.13 | 0.16 | 0.18 | 0.55 |
Total Current Liabilities | 2.96 | 3.8 | 2.96 | 3.28 | 3.19 | 2.83 |
Long-Term Leases | - | 0.02 | 0.21 | 0.41 | 0.52 | 0.69 |
Long-Term Deferred Tax Liabilities | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Total Liabilities | 3.16 | 4.02 | 3.37 | 3.89 | 3.91 | 3.73 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Additional Paid-In Capital | 481 | 480.41 | 479.34 | 478.15 | 477.44 | 476.79 |
Retained Earnings | -443.65 | -438.75 | -426.75 | -415.7 | -407.13 | -393.06 |
Comprehensive Income & Other | -0.13 | -0.13 | -0.14 | -0.12 | -0.12 | -0.1 |
Total Common Equity | 37.27 | 41.59 | 52.5 | 62.38 | 70.24 | 83.68 |
Shareholders' Equity | 37.27 | 41.59 | 52.5 | 62.38 | 70.24 | 83.68 |
Total Liabilities & Equity | 40.43 | 45.6 | 55.88 | 66.27 | 74.15 | 87.41 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.12 | 0.21 | 0.41 | 0.63 | 0.68 | 0.83 |
Net Cash (Debt) | 25.3 | 30.6 | 39.95 | 50.37 | 57.81 | 70.6 |
Net Cash Growth | -25.50% | -23.43% | -20.68% | -12.86% | -18.13% | 17.97% |
Net Cash Per Share | 0.51 | 0.62 | 0.81 | 1.03 | 1.18 | 1.45 |
Filing Date Shares Outstanding | 49.22 | 49.22 | 49.05 | 49.05 | 49.05 | 49.04 |
Total Common Shares Outstanding | 49.22 | 49.22 | 49.05 | 49.05 | 49.05 | 49.04 |
Working Capital | 22.96 | 27.19 | 38.12 | 47.9 | 55.8 | 69.18 |
Book Value Per Share | 0.76 | 0.84 | 1.07 | 1.27 | 1.43 | 1.71 |
Tangible Book Value | 22.87 | 27.19 | 38.1 | 47.98 | 55.84 | 69.28 |
Tangible Book Value Per Share | 0.46 | 0.55 | 0.78 | 0.98 | 1.14 | 1.41 |
Machinery | - | 0.09 | 0.09 | 0.13 | 0.12 | 0.12 |
Leasehold Improvements | - | - | - | 0.01 | 0.01 | 0.02 |